These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 21094231

  • 21. Inducing effect of liposomalization on the transdermal delivery of hydrocortisone: creation of a drug supersaturated state.
    Barichello JM, Handa H, Kisyuku M, Shibata T, Ishida T, Kiwada H.
    J Control Release; 2006 Sep 28; 115(1):94-102. PubMed ID: 16919352
    [Abstract] [Full Text] [Related]

  • 22. An in vitro and in vivo comparison of solid and liquid-oil cores in transdermal aconitine nanocarriers.
    Zhang YT, Wu ZH, Zhang K, Zhao JH, Ye BN, Feng NP.
    J Pharm Sci; 2014 Nov 28; 103(11):3602-3610. PubMed ID: 25187419
    [Abstract] [Full Text] [Related]

  • 23. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil.
    Mura S, Manconi M, Sinico C, Valenti D, Fadda AM.
    Int J Pharm; 2009 Oct 01; 380(1-2):72-9. PubMed ID: 19589377
    [Abstract] [Full Text] [Related]

  • 24. Development and characterization of nanoparticles of glibenclamide by solvent displacement method.
    Dora CP, Singh SK, Kumar S, Datusalia AK, Deep A.
    Acta Pol Pharm; 2010 Oct 01; 67(3):283-90. PubMed ID: 20524431
    [Abstract] [Full Text] [Related]

  • 25. Lipid vesicles and other colloids as drug carriers on the skin.
    Cevc G.
    Adv Drug Deliv Rev; 2004 Mar 27; 56(5):675-711. PubMed ID: 15019752
    [Abstract] [Full Text] [Related]

  • 26. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
    Reitamo S, Harper J, Bos JD, Cambazard F, Bruijnzeel-Koomen C, Valk P, Smith C, Moss C, Dobozy A, Palatsi R, European Tacrolimus Ointment Group.
    Br J Dermatol; 2004 Mar 27; 150(3):554-62. PubMed ID: 15030341
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Compounding of a topical drug with prospective natural surfactant-stabilized pharmaceutical bases: physicochemical and in vitro/in vivo characterization--a ketoprofen case study.
    Jaksic I, Lukic M, Malenovic A, Reichl S, Hoffmann C, Müller-Goymann C, Daniels R, Savic S.
    Eur J Pharm Biopharm; 2012 Jan 27; 80(1):164-75. PubMed ID: 21939763
    [Abstract] [Full Text] [Related]

  • 31. Hydrocortisone (cortisol) concentration and penetration gradient.
    Kranz G, Schaefer H, Zesch A.
    Acta Derm Venereol; 1977 Jan 27; 57(3):269-73. PubMed ID: 71836
    [Abstract] [Full Text] [Related]

  • 32. Topical delivery of lipophilic drugs from o/w Pickering emulsions.
    Frelichowska J, Bolzinger MA, Pelletier J, Valour JP, Chevalier Y.
    Int J Pharm; 2009 Apr 17; 371(1-2):56-63. PubMed ID: 19135516
    [Abstract] [Full Text] [Related]

  • 33. Dual influence of colloidal silica on skin deposition of vitamins C and E simultaneously incorporated in topical microemulsions.
    Rozman B, Gosenca M, Gasperlin M, Padois K, Falson F.
    Drug Dev Ind Pharm; 2010 Jul 17; 36(7):852-60. PubMed ID: 20515405
    [Abstract] [Full Text] [Related]

  • 34. Dermal peptide delivery using enhancer molecules and colloidal carrier systems. Part III: Tetrapeptide GEKG.
    Sommer E, Neubert RHH, Mentel M, Tuchscherer B, Mrestani Y, Wohlrab J.
    Eur J Pharm Sci; 2018 Nov 01; 124():137-144. PubMed ID: 30165235
    [Abstract] [Full Text] [Related]

  • 35. Health-related utility among adults with atopic dermatitis treated with 0.1% tacrolimus ointment as maintenance therapy over the long term: findings from the Protopic CONTROL study.
    Poole CD, Chambers C, Sidhu MK, Currie CJ.
    Br J Dermatol; 2009 Dec 01; 161(6):1335-40. PubMed ID: 19754867
    [Abstract] [Full Text] [Related]

  • 36. Ionic liquid-in-oil microemulsion as a potential carrier of sparingly soluble drug: characterization and cytotoxicity evaluation.
    Moniruzzaman M, Tamura M, Tahara Y, Kamiya N, Goto M.
    Int J Pharm; 2010 Nov 15; 400(1-2):243-50. PubMed ID: 20813174
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y, Pan J, Feng SS.
    Int J Pharm; 2010 Aug 16; 395(1-2):243-50. PubMed ID: 20472049
    [Abstract] [Full Text] [Related]

  • 40. Feasibility studies of dermal delivery of paclitaxel with binary combinations of ethanol and isopropyl myristate: role of solubility, partitioning and lipid bilayer perturbation.
    Panchagnula R, Desu H, Jain A, Khandavilli S.
    Farmaco; 2005 Aug 16; 60(11-12):894-9. PubMed ID: 16126203
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.